Eklira Genuair - Aclidinium bromide
Covis Pharma Europe B.V.
Description
Antimuscarinic bronchodilator.
• Over 18 years: by inhalation of powder, 375 mcg (1 inhalation), twice daily.
Indications
For maintenance treatment of COPD.
Contraindications
Avoid in the case of pregnancy and breast feeding.
Preparations Available
Inhalation powder
Sizes Available
Inhalation powder
Eklira Genuair 322 mcg/dose, 60 doses
More on: Bronchodilators , Antimuscarinic bronchodilators